• Honokiol: Applied Workflows and Troubleshooting in Cancer Re

  2026-05-06

  Honokiol, a potent NF-κB pathway inhibitor and antioxidant, empowers researchers with reproducible, multi-modal workflows for cancer and inflammation studies. This article delivers data-driven protocols, advanced troubleshooting strategies, and actionable insights—bridging foundational findings to robust in vitro assay design.

• Actinomycin D in Stem Cell Epigenetics: Beyond Transcription

  2026-05-06

  Explore the advanced applications of Actinomycin D in stem cell epigenetics and osteogenic differentiation. This article uniquely connects ActD’s transcriptional inhibition to emerging insights on m6A modification and practical assay optimization.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-05-05

  Schwartz's dissertation introduces a rigorous framework for distinguishing between cell growth inhibition and cell death in the evaluation of anti-cancer drugs in vitro. By dissecting these response metrics, the study provides a more nuanced approach to preclinical oncology research, with implications for the assessment of targeted therapies such as tyrosine kinase inhibitors.

• Mianserin HCl in Advanced Antidepressant and Antipathogenic

  2026-05-05

  Explore the unique dual action of Mianserin HCl as a 5-HT2 receptor antagonist in cutting-edge antidepressant and antipathogenic research. This article delivers new insights into assay design, inclusion complexation, and translational applications beyond established reviews.

• Capsaicin in Translational Research: From TRPV1 to Epigeneti

  2026-05-04

  This thought-leadership article explores (E)-Capsaicin’s unique duality as both a potent TRPV1 ion channel activator and KDM1A/LSD1 inhibitor, positioning it as a strategic tool in pain, inflammation, and gastric cancer research. Integrating mechanistic evidence, recent clinical-grade findings, and protocol guidance, the article delivers actionable insights for translational researchers while highlighting APExBIO's Capsaicin as a next-generation research asset.

• c-Myc tag Peptide: Advanced Immunoassay Workflows & Troubles

  2026-05-04

  The c-Myc tag Peptide empowers high-specificity displacement of c-Myc-tagged fusion proteins, yielding cleaner immunoassay results and facilitating precise studies of transcription factor regulation. This guide presents optimized protocols, advanced applications, and field-tested troubleshooting strategies, bridging the latest insights from autophagy research to maximize your assay’s reliability.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mou

  2026-05-03

  This study investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of major Corydalis saxicola Bunting total alkaloids in mice. The results reveal how disease-driven changes in hepatic enzymes and transporters, particularly cytochrome P450s and PXR-mediated pathways, impact drug exposure and inform rational dosing for MASLD/MASH treatment.

• Capsaicin for TRPV1 Research: Protocols, Assays & Troublesho

  2026-05-02

  Capsaicin ((E)-Capsaicin) is a dual-action modulator, uniquely enabling advanced dissection of pain and itch signaling via TRPV1 activation and KDM1A/LSD1 inhibition. This article delivers actionable workflows, troubleshooting guidance, and context from landmark studies to optimize both cell-based and animal model applications.

• Cardiac Biomarkers in Epileptic Baboons: Implications for SU

  2026-05-01

  This study identifies QT-interval prolongation and reduced heart rate variability as significant cardiac biomarkers in epileptic baboons, providing new insights into SUDEP risk. The findings advance the use of the baboon model for mechanistic studies of epilepsy-related cardiac dysfunction.

• Verbascoside: Applied PKC/NF-κB Inhibition in Osteoclastogen

  2026-05-01

  Verbascoside, a validated PKC/NF-κB inhibitor, empowers precise modulation of osteoclastogenesis, neuroinflammatory, and cell signaling assays. Learn to optimize your workflows, troubleshoot common pitfalls, and translate advanced mechanistic insights into reproducible results using APExBIO's high-purity reagent.

• Remdesivir (GS-5734) in Advanced Antiviral Research Workflow

  2026-04-30

  Remdesivir (GS-5734) stands as a benchmark antiviral nucleoside analogue for dissecting RNA virus replication and testing therapeutic hypotheses. This article details practical workflows, troubleshooting strategies, and cross-virus applications that leverage its unique mode of action and validated potency, empowering high-impact coronavirus and Ebola research.

• Remdesivir (GS-5734): Structural Insights Transforming Antiv

  2026-04-30

  Explore Remdesivir (GS-5734) as a next-generation antiviral through a structural biology lens. This article uniquely connects polymerase complex structures to practical assay design, revealing how APExBIO's Remdesivir empowers advanced coronavirus and Ebola virus research.

• Apicidin as a Histone Deacetylase Inhibitor: Applied Workflo

  2026-04-29

  Apicidin stands out as a highly selective histone deacetylase inhibitor for dissecting epigenetic regulation in cancer and reproductive models. This guide delivers actionable workflow protocols, troubleshooting insights, and strategic integration tips to maximize its anti-proliferative and anti-angiogenesis potential in translational research.

• METTL14-m6A Pathway Modulates UC Inflammation via lncRNA Axi

  2026-04-29

  This study demonstrates that METTL14, a methyltransferase complex subunit, protects against ulcerative colitis (UC) inflammation by regulating m6A modification on the lncRNA DHRS4-AS1, which in turn modulates the miR-206/A3AR signaling axis. These findings clarify an epigenetic mechanism underpinning inflammatory responses in UC and suggest new avenues for targeting m6A-dependent pathways in preclinical research.

• Epinephrine Bitartrate: Mechanistic and Translational Insigh

  2026-04-28

  Explore how (-)-Epinephrine (+)-bitartrate advances adrenergic signaling research, bridging mechanistic understanding with strategic translational workflows. This article delivers evidence-driven guidance on optimizing in vitro and in vivo experiments, analyzes emerging clinical delivery routes, and distinguishes APExBIO’s offering by integrating pharmacokinetic, application, and workflow expertise. Comparative insights and critical perspectives on the evolving landscape equip translational researchers to maximize impact in cardiovascular and neurobiology studies.

413 records 10/28 page Previous Next First page 上5页 678910 下5页 Last page